JP Morgan Chase’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-166,808
Closed -$6.94M 7835
2023
Q2
$6.94M Sell
166,808
-85,412
-34% -$3.51M ﹤0.01% 2608
2023
Q1
$10.4M Sell
252,220
-1,821,217
-88% -$77.9M ﹤0.01% 2249
2022
Q4
$85.5M Sell
2,073,437
-306,859
-13% -$12.4M 0.01% 844
2022
Q3
$104M Sell
2,380,296
-557,999
-19% -$27M 0.02% 714
2022
Q2
$144M Sell
2,938,295
-137,709
-4% -$7.39M 0.02% 613
2022
Q1
$174M Buy
3,076,004
+49,684
+2% +$2.64M 0.02% 608
2021
Q4
$159M Buy
3,026,320
+108,526
+4% +$5.9M 0.02% 672
2021
Q3
$175M Sell
2,917,794
-102,793
-3% -$6.34M 0.02% 618
2021
Q2
$205M Buy
3,020,587
+1,210,305
+67% +$82.6M 0.02% 593
2021
Q1
$119M Buy
1,810,282
+1,332,888
+279% +$80M 0.02% 769
2020
Q4
$26.9M Sell
477,394
-69,059
-13% -$3.4M ﹤0.01% 1410
2020
Q3
$25.9M Buy
546,453
+56,074
+11% +$3.02M ﹤0.01% 1329
2020
Q2
$27.3M Buy
490,379
+195,454
+66% +$11.3M 0.01% 1180
2020
Q1
$14.9M Sell
294,925
-30,379
-9% -$2.04M ﹤0.01% 1448
2019
Q4
$25.2M Sell
325,304
-508,830
-61% -$35.9M ﹤0.01% 1410
2019
Q3
$52.9M Buy
834,134
+603,660
+262% +$37.7M 0.01% 916
2019
Q2
$13.3M Buy
230,474
+17,017
+8% +$1M ﹤0.01% 1877
2019
Q1
$12.1M Buy
213,457
+27,049
+15% +$1.44M ﹤0.01% 1881
2018
Q4
$9.24M Sell
186,408
-2,568
-1% -$154K ﹤0.01% 2081
2018
Q3
$13.4M Sell
188,976
-42,015
-18% -$2.67M ﹤0.01% 1965
2018
Q2
$12M Buy
230,991
+50,292
+28% +$2.63M ﹤0.01% 1990
2018
Q1
$9.44M Buy
180,699
+66,961
+59% +$3.4M ﹤0.01% 2068
2017
Q4
$6.65M Buy
113,738
+77,811
+217% +$4.41M ﹤0.01% 2442
2017
Q3
$1.98M Sell
35,927
-768
-2% -$50.8K ﹤0.01% 3165
2017
Q2
$2.82M Buy
36,695
+872
+2% +$65.2K ﹤0.01% 2847
2017
Q1
$2.68M Sell
35,823
-107,417
-75% -$7.79M ﹤0.01% 2854
2016
Q4
$9.65M Sell
143,240
-2,005
-1% -$129K ﹤0.01% 1935
2016
Q3
$9.68M Sell
145,245
-38,232
-21% -$2.44M ﹤0.01% 1816
2016
Q2
$11M Sell
183,477
-20,600
-10% -$1.11M ﹤0.01% 1768
2016
Q1
$9.93M Sell
204,077
-106,783
-34% -$4.85M ﹤0.01% 1778
2015
Q4
$16.8M Sell
310,860
-7,494
-2% -$382K ﹤0.01% 1462
2015
Q3
$15.4M Sell
318,354
-188,193
-37% -$9.73M ﹤0.01% 1445
2015
Q2
$24M Sell
506,547
-151,205
-23% -$7.07M 0.01% 1292
2015
Q1
$30.3M Sell
657,752
-180,254
-22% -$8.37M 0.01% 1169
2014
Q4
$39.5M Sell
838,006
-41,271
-5% -$1.72M 0.01% 1054
2014
Q3
$30.7M Sell
879,277
-220,982
-20% -$7.86M 0.01% 1185
2014
Q2
$39.1M Sell
1,100,259
-336,366
-23% -$11.5M 0.01% 973
2014
Q1
$55.2M Buy
1,436,625
+29,426
+2% +$1.08M 0.02% 757
2013
Q4
$45.5M Sell
1,407,199
-117,309
-8% -$3.52M 0.01% 863
2013
Q3
$37.3M Buy
1,524,508
+432,460
+40% +$10.6M 0.01% 958
2013
Q2
$27.1M Buy
+1,092,048
New +$23.9M 0.01% 1064

Other funds holding NUVA

JP Morgan Chase's NUVA Position: Q3 2023 in Review

JP Morgan Chase sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 166,808 shares — an estimated $6.94M sold.

JP Morgan Chase first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $205M in Q2 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • JP Morgan Chase reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Chase sold 166,808 NuVasive, Inc. shares in Q3 2023, an estimated $6.94M.
  • JP Morgan Chase first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • JP Morgan Chase's NuVasive, Inc. position peaked at $205M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.